³í¹®) Increased risk of incident diabetes after therapy with immune checkpoint inhibitor compared with conventional chemotherapy: A longitudinal trajectory analysis using a tertiary care hospital database
¿¬¼¼´ë ¼¼ºê¶õ½ºº´¿ø ³»ºÐºñ³»°ú ÀÌÀ¯¹Ì, À̹οµ ±³¼ö¿Í ÀÇ°ú´ëÇÐ ÀÇ»ý¸í½Ã½ºÅÛÁ¤º¸Çб³½Ç ¹ÚÀ¯¶û ±³¼ö, Á¤°æ¼· ¿¬±¸¿ø ¿¬±¸ÆÀ